DE69739051D1 - Östrogen-Sulfamate als Sulfataseinhibitoren - Google Patents

Östrogen-Sulfamate als Sulfataseinhibitoren

Info

Publication number
DE69739051D1
DE69739051D1 DE69739051T DE69739051T DE69739051D1 DE 69739051 D1 DE69739051 D1 DE 69739051D1 DE 69739051 T DE69739051 T DE 69739051T DE 69739051 T DE69739051 T DE 69739051T DE 69739051 D1 DE69739051 D1 DE 69739051D1
Authority
DE
Germany
Prior art keywords
group
ring
sulfatase inhibitors
compound
estrogen sulfamates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69739051T
Other languages
English (en)
Inventor
Michael J Reed
Barry V L Potter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sterix Ltd
Original Assignee
Sterix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterix Ltd filed Critical Sterix Ltd
Application granted granted Critical
Publication of DE69739051D1 publication Critical patent/DE69739051D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69739051T 1996-12-05 1997-12-04 Östrogen-Sulfamate als Sulfataseinhibitoren Expired - Lifetime DE69739051D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9625334.9A GB9625334D0 (en) 1996-12-05 1996-12-05 Compound

Publications (1)

Publication Number Publication Date
DE69739051D1 true DE69739051D1 (de) 2008-11-27

Family

ID=10804019

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69722240T Expired - Lifetime DE69722240T2 (de) 1996-12-05 1997-12-04 Sulfataseinhibitoren
DE69739051T Expired - Lifetime DE69739051D1 (de) 1996-12-05 1997-12-04 Östrogen-Sulfamate als Sulfataseinhibitoren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69722240T Expired - Lifetime DE69722240T2 (de) 1996-12-05 1997-12-04 Sulfataseinhibitoren

Country Status (10)

Country Link
EP (2) EP1310508B1 (de)
JP (1) JP2001505221A (de)
AT (2) ATE411335T1 (de)
AU (1) AU5402398A (de)
DE (2) DE69722240T2 (de)
DK (1) DK0942919T3 (de)
ES (2) ES2314020T3 (de)
GB (1) GB9625334D0 (de)
PT (1) PT942919E (de)
WO (1) WO1998024802A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
US6903084B2 (en) 1991-08-29 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
WO1999064013A1 (en) * 1998-06-10 1999-12-16 Sterix Limited Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase
GB2331987B (en) * 1997-12-04 2002-11-27 Imperial College Polycyclic sulphamate inhibitors of oestrone sulphatase
GB2331988B (en) * 1997-12-04 2003-04-16 Imperial College Polycyclic sulphamate inhibitors or oestrone sulphatase
US6046186A (en) * 1997-12-24 2000-04-04 Sri International Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
JP2000309599A (ja) 1999-04-13 2000-11-07 Kyowa Hakko Kogyo Co Ltd エストラ−１，３，５（１０），１６−テトラエン誘導体
US7078395B1 (en) 1999-06-16 2006-07-18 Sterix Limited Methods for treating or preventing cancer by preventing, inhibiting or arresting cell cycling
JP5042411B2 (ja) 1999-04-30 2012-10-03 ステリックス リミテッド 抗腫瘍剤としてのエストロン誘導体の使用
AU2005225148B2 (en) * 1999-04-30 2008-04-03 Sterix Limited Use
GB9913536D0 (en) * 1999-06-10 1999-08-11 Sterix Ltd Use
DK1237902T3 (da) 1999-12-13 2006-03-06 Sterix Ltd Halogenerede sulphamat-, fosfonat-, thiofosfonat-, sulfonat- og sulfonamidforbindelser som hæmmere af steroid sulfatase
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
AU2001248849A1 (en) 2000-04-24 2001-11-07 Kyowa Hakko Kogyo Co. Ltd. Estra-1,3,5(10)-triene derivatives
WO2002015910A1 (en) 2000-08-18 2002-02-28 Sterix Limited 2-substituted estradiol derivative for inhibiting superoxid dismutase
GB0020498D0 (en) * 2000-08-18 2000-10-11 Sterix Ltd Compound
GB0025788D0 (en) * 2000-10-20 2000-12-06 Sterix Ltd Use
US8026229B2 (en) 2001-08-13 2011-09-27 Sterix Limited Antitumor-active 2-alkoxyestradiol sulfamates
DE10307104A1 (de) * 2003-02-19 2004-09-23 Schering Ag Antitumor wirksame 2-substituierte Estra-1,3,5(10)-trien-3-yl sulfamate
DE10307103A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
DE10307105A1 (de) * 2003-02-19 2004-09-09 Schering Ag Antitumor wirksame 2-substituierte 18a-Homoestra-1,3,5(10)-trien-3-yl sulfamate
CA2698814A1 (en) 2007-09-17 2009-03-26 Preglem S.A. Treatment of oestrogen dependant conditions in pre-menopausal women

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668668A (en) * 1984-03-20 1987-05-26 Wayne State University Compositions inhibiting murine MXT ductal carcinoma
GB9118478D0 (en) * 1991-08-29 1991-10-16 Imperial College Steroid sulphatase inhibitors
DE4429398C2 (de) * 1994-08-09 1997-09-11 Jenapharm Gmbh Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption

Also Published As

Publication number Publication date
EP1310508A3 (de) 2004-12-08
ES2200201T3 (es) 2004-03-01
ES2314020T3 (es) 2009-03-16
ATE240968T1 (de) 2003-06-15
EP0942919B1 (de) 2003-05-21
EP1310508B1 (de) 2008-10-15
DE69722240D1 (de) 2003-06-26
WO1998024802A3 (en) 1998-08-27
DK0942919T3 (da) 2003-09-15
ATE411335T1 (de) 2008-10-15
DE69722240T2 (de) 2004-04-01
EP1310508A2 (de) 2003-05-14
EP0942919A2 (de) 1999-09-22
WO1998024802A2 (en) 1998-06-11
GB9625334D0 (en) 1997-01-22
JP2001505221A (ja) 2001-04-17
AU5402398A (en) 1998-06-29
PT942919E (pt) 2003-10-31

Similar Documents

Publication Publication Date Title
ATE411335T1 (de) Östrogen-sulfamate als sulfataseinhibitoren
CY2559B1 (en) Non-steroidal polycyclic ring su lphamate derivatives, their preparation and their use as oestrone sulphatase inhibitors
GB2331988B (en) Polycyclic sulphamate inhibitors or oestrone sulphatase
DE69841374D1 (de) 3-o-sulfamatsteroidderivate als hemmer von estronsulfatase
PT82945A (pt) Processo para a preparacao de novos derivados de 2,3-di-hidro-benzofurano
DK288686A (da) Farmaceutiske praeparater
ES2099879T3 (es) 5-oxo-dibenzo(a,d)ciclohepta-1,4-dienos y su uso como agentes retrovirales.
SE7704616L (sv) Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat
MX170732B (es) Composicion de derivados de succinimida y su uso
FR2501676B1 (de)
ATE77744T1 (de) Verwendung von pyrrothinderivaten.
EP0139907A3 (en) Estrane derivatives
MY122562A (en) Antibacterial composition
TR199701011A2 (xx) 1-karba-(detia)-sefalosforin t�revleri.
DE59204299D1 (de) 14Alpha,17alpha-(Propano- und 17,2-Propeno)-estratriene.
FR2638221B1 (fr) Installation permettant l'elimination par combustion de dechets divers
ES1016509U (es) Soporte perfeccionado, para herramienta manual.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition